赞助商

 


Corporate Sponsors

    Curia    OmniAb  SpiroChem  STEMCELL-Technologies

Corporate Support Sponsors

Ardigen_new Aurigene_Pharmaceutical_Services_NEW  Biointron_newbiosensing-instrument-logoBPS Bioscience NEWCovaLX      GENOVAC  Medicilon  OpenEye_TaglinePromega SaiSyngene_tagline  Wuxi-Apptecx-chem_Pharmaceuticals  

Choose your language
Chinese
Japanese
Korean
English

早期優惠
05月23日前報名參加
最高可優惠 $600OFF
Conference at a Glance
View Event Testimonial Highlights
Submit a Poster
View All Sponsors

会议议程节目

9月22日

Covalent Chemistries & Induced Proximity
共价化学和诱导接近 Strategies for Targeting Kinases
靶向激酶的策略 Emerging Immune Modulation Strategies
新兴的免疫调节策略 3D Models & NAMs in Drug Development
药物开发中的 3D 模型和 NAMs Synthetic Biology for Drug Discovery & Development
用于药物发现和开发的合成生物学

9月23日 - 24日

Degraders & Molecular Glues – Part 1
降解剂和分子胶 - PART1 Emerging Drug Targets: Identification & Validation
新兴药物靶点：鉴定与验证 Small Molecules for Cancer Targets
用于癌症靶点的小分子 Antibodies Against Membrane Protein Targets
针对膜蛋白靶标的抗体 RNA & DNA Targeting Small Molecule Drugs
RNA & DNA 靶向小分子药物 AI/ML-Enabled Drug Discovery - Part 1
AI/ML 支援的药物发现 - PART1 Targeting MASH & Obesity NEW
针对MASH和肥胖

9月24日 - 25日

Degraders & Molecular Glues – Part 2
降解剂和分子胶 - PART2 Lead Generation Strategies
潜在客户开发策略 Emerging Cancer Targets for Multispecifics, ADCs, and Biologics
多特异性抗体、抗体偶联药物 (ADC) 和生物制剂中的新兴癌症标靶 GPCR-Based Drug Discovery
基于GPCR的药物发现 Targeting Transcription Factors & Regulators
靶向转录因子和调控因子 AI/ML-Enabled Drug Discovery - Part 2
AI/ML 支援的药物发现 - PART2 TS: Drug Exposure at the Target: The Role of ADME and Pharmacokinetics
TS：标靶药物暴露：ADME 和药物动力学的作用